Roberto Badagliacca

Pubblicazioni

Titolo Pubblicato in Anno
Impact of parenteral prostanoids in pulmonary arterial hypertension. the relevance of timing JOURNAL OF CLINICAL MEDICINE 2023
Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysis INTERNATIONAL JOURNAL OF CARDIOLOGY 2023
New Challenges in Heart Failure with Reduced Ejection Fraction: Managing Worsening Events JOURNAL OF CLINICAL MEDICINE 2023
Exploratory study on the endogenous ouabain in idiopathic pulmonary arterial hypertension patients ANNALI DELL'ISTITUTO SUPERIORE DI SANITÀ 2023
Heart failure patients with improved ejection fraction: Insights from the MECKI score database EUROPEAN JOURNAL OF HEART FAILURE 2023
Real‐world evidence to advance knowledge in pulmonary hypertension. status, challenges, and opportunities. a consensus statement from the pulmonary vascular research institute's innovative drug development initiative's real‐world evidence working group PULMONARY CIRCULATION 2023
IABP versus impella support in cardiogenic shock. “in silico” study JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE 2023
Modelling and simulation of the combined use of IABP and impella as a rescue procedure in cardiogenic shock. an alternative for non-transplant centres BIOENGINEERING 2023
Exploring theprognostic performance of MECKI score in heart failure patients with non-valvular atrial fibrillation treated with edoxaban JOURNAL OF CLINICAL MEDICINE 2023
Computational simulator models and invasive hemodynamic monitoring as tools for precision medicine in pulmonary arterial hypertension JOURNAL OF CLINICAL MEDICINE 2022
Hemodynamic evaluation of the right heart-pulmonary circulation unit in patients candidate to transjugular intrahepatic portosystemic shunt JOURNAL OF CLINICAL MEDICINE 2022
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? EUROPEAN RESPIRATORY JOURNAL 2022
Role of cardiopulmonary exercise test in the prediction of hemodynamic impairment in patients with pulmonary arterial hypertension PULMONARY CIRCULATION 2022
Future perspective in diabetic patients with pre- and post-capillary pulmonary hypertension HEART FAILURE REVIEWS 2022
Aggressive afterload lowering to improve the right ventricle a new target for medical therapy in pulmonary arterial hypertension AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2022
Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension THE JOURNAL OF HEART AND LUNG TRANSPLANTATION 2022
Sex-specific effects of daily tadalafil on diabetic heart kinetics in RECOGITO, a randomized, double-blind, placebo-controlled trial SCIENCE TRANSLATIONAL MEDICINE 2022
β-Blockers and Erectile Dysfunction in Heart Failure. Between Myth and Reality REVIEWS IN CARDIOVASCULAR MEDICINE 2022
Pick your threshold: a comparison among different methods of anaerobic threshold evaluation in heart failure prognostic assessment CHEST 2022
Telehealth. a winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension VASCULAR PHARMACOLOGY 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma